Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Brenda VanLunen"'
Autor:
Martin Rudwaleit, James T Rosenbaum, Irene van der Horst-Bruinsma, Maria Misterska-Skora, Rianne van Bentum, Frank D Verbraak, Thomas Rath, Bengt Hoepken, Oscar Irvin-Sellers, Brenda VanLunen, Lars Bauer
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Background Acute anterior uveitis (AAU) is the most common extra-articular manifestation in patients with axial spondyloarthritis (axSpA). C-VIEW investigates the impact of the Fc-free TNF inhibitor certolizumab pegol (CZP) on AAU flares in patients
Externí odkaz:
https://doaj.org/article/6339948a645946ac82c8b7b88be8913f
Autor:
Niti Goel, O. Davies, Frank McKenna, Ernest Choy, Hans-Detlev Stahl, Rieke Alten, Robert M. Valente, Brenda VanLunen, Jiri Vencovsky
Publikováno v:
Rheumatology. 51:1226-1234
Objective. Certolizumab pegol (CZP) is known to be effective as monotherapy at a dosage of 400 mg every 4 weeks in patients with active RA who have failed DMARDs. The aim of this study was to investigate every 4-week CZP in addition to continued MTX
Autor:
Laura Shaughnessy, Brenda vanLunen, Robert Landewé, Edward Keystone, Ronald van Vollenhoven, Bernard Combe, Vibeke Strand, Desirée van der Heijde, Philip J. Mease
Publikováno v:
Rheumatology. 53:i96-i96